Stock Analysis

Lasertec Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

TSE:6920
Source: Shutterstock

Lasertec Corporation (TSE:6920) just released its latest quarterly results and things are looking bullish. Statutory revenue of JP¥62b and earnings of JP¥214 both blasted past expectations, beating expectations by 30% and 62%, respectively, ahead of expectations. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

View our latest analysis for Lasertec

earnings-and-revenue-growth
TSE:6920 Earnings and Revenue Growth May 2nd 2024

Taking into account the latest results, the current consensus from Lasertec's 15 analysts is for revenues of JP¥269.3b in 2025. This would reflect a solid 17% increase on its revenue over the past 12 months. Statutory earnings per share are predicted to soar 25% to JP¥925. In the lead-up to this report, the analysts had been modelling revenues of JP¥266.0b and earnings per share (EPS) of JP¥913 in 2025. The consensus analysts don't seem to have seen anything in these results that would have changed their view on the business, given there's been no major change to their estimates.

It will come as no surprise then, to learn that the consensus price target is largely unchanged at JP¥39,286. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. The most optimistic Lasertec analyst has a price target of JP¥50,000 per share, while the most pessimistic values it at JP¥23,000. Note the wide gap in analyst price targets? This implies to us that there is a fairly broad range of possible scenarios for the underlying business.

Of course, another way to look at these forecasts is to place them into context against the industry itself. It's pretty clear that there is an expectation that Lasertec's revenue growth will slow down substantially, with revenues to the end of 2025 expected to display 13% growth on an annualised basis. This is compared to a historical growth rate of 40% over the past five years. Juxtapose this against the other companies in the industry with analyst coverage, which are forecast to grow their revenues (in aggregate) 13% annually. So it's pretty clear that, while Lasertec's revenue growth is expected to slow, it's expected to grow roughly in line with the industry.

The Bottom Line

The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. They also reconfirmed their revenue estimates, with the company predicted to grow at about the same rate as the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have estimates - from multiple Lasertec analysts - going out to 2026, and you can see them free on our platform here.

You should always think about risks though. Case in point, we've spotted 2 warning signs for Lasertec you should be aware of, and 1 of them is significant.

Valuation is complex, but we're helping make it simple.

Find out whether Lasertec is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.